What Risks Are Associated With SBRT Treatment?

Stereotactic body radiation therapy (SBRT) aims a few very high doses of radiation precisely at a tumor, and for most people the side effects are mild or manageable. Because each dose is so strong, the risks depend mostly on what healthy tissue sits right next to the tumor, so a lung patient and a prostate patient face quite different problems. A minority of people carry specific traits that turn a normally safe treatment into a serious risk, which is why your own health history matters as much as the treatment itself.

How Often SBRT Causes Problems and When They Appear

Doses above roughly 8 to 10 Gy per session damage the small blood vessels feeding a tumor, which starves cancer cells beyond the direct hit.1Radiation Oncology Journal. Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery That same vessel damage can affect healthy tissue caught in the high-dose zone, which is why location drives risk.2PubMed. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death Doctors grade side effects from 1 (mild) to 5 (fatal), and most SBRT effects fall in grades 1 or 2.

Grade 1 is noticeable but needs no treatment. Grade 2 usually means you need medicine or simple care. Grade 3 or higher means hospital care, procedures, or limits on what you can do day to day.

Timing matters as much as grade. Early effects, such as tiredness or an irritated bladder, appear during treatment or within weeks. Late effects, such as fractures or scarring, can show up many months later, long after you feel finished. The same grade can also mean different things in different organs. Mild irritation of the bladder lining is an annoyance, but the same degree of injury to a bowel wall or the spinal cord can be far more consequential. Organs made of repeating units, like the lung and liver, can often lose a small part without any noticeable effect, while tube-shaped organs such as the bowel, urethra and airways can cause trouble from one small injured stretch.

After treatment, a new symptom may come from SBRT, from the cancer, or from something unrelated such as an infection. Timing and a scan or blood test help sort these out. Scans can also show changes in the treated area that look worrying but are often scar-like or inflammatory changes from the radiation, so your team may compare several scans over time.

In people treated for early lung cancer, quality-of-life scores were essentially the same a year after SBRT as before it.3PubMed. A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer After kidney SBRT, overall wellbeing and fatigue dipped in the first week before recovering.4PubMed. Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study In lung patients, pain, low energy and cough were somewhat worse at 12 weeks, while worry and nervousness eased over time.5PubMed Central. Quality of life and symptoms following stereotactic body radiotherapy in early-stage lung cancer patients

Lung and Chest Wall Risks

The most common lung side effect is radiation pneumonitis, inflammation of the lung tissue around the treated area, often showing as cough or breathlessness.6PubMed Central. Radiation pneumonitis after stereotactic radiation therapy for lung cancer Between 9% and 28% of people develop symptoms from it, most cases mild or treatable with medicine.6PubMed Central. Radiation pneumonitis after stereotactic radiation therapy for lung cancer A few cases are severe and can be life-threatening.6PubMed Central. Radiation pneumonitis after stereotactic radiation therapy for lung cancer Risk rises with lung conditions you already have, previous chest radiation, a tumor in the right lung, and more healthy lung receiving dose.7PubMed. Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer A larger tumor target also raises the risk, while age on its own does not.8PubMed Central. Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies

Pneumonitis often starts weeks to months after the last session. Mild cases may cause only a dry cough, a low fever, or slight breathlessness on stairs, which is easy to mistake for a cold or chest infection, so compare with your usual breathing. Doctors usually confirm it with a chest scan and by ruling out infection, since the treatments differ. Report new breathlessness promptly rather than waiting for your next visit.

Symptomatic cases are usually treated with steroid medicine, often started at a higher dose and tapered gradually over weeks. Stopping too quickly can let symptoms return, so follow the tapering plan you are given. Most mild cases settle, though some people are left with a small area of scarring on the scan that causes no symptoms.

Chest wall pain affects about 9% of people after lung SBRT and rib fractures about 5% across many studies.9PubMed Central. Chest wall toxicity after stereotactic radiation in early lung cancer: a systematic review In longer follow-up, about 19% had a rib fracture, with risk climbing from 6 months to about 4.5 years after treatment.10PubMed. Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancer Only about a third of rib fractures caused pain, and nearly all happened without any injury.11PubMed Central. Predictors and characteristics of Rib fracture following SBRT for lung tumors

Tumors close to the ribs expose more bone to high dose, so it is worth asking whether yours sits near the chest wall. A painless fracture found on a scan often needs no treatment.

Liver Risks Depend on How Healthy Your Liver Is

Doctors rate liver health with a Child-Pugh score, from 5 (best) upward; you may see it as “CP-A5” or “Class B” on reports.12PubMed Central. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma Radiation liver damage after SBRT occurred in about 6% of people with a score of 5.12PubMed Central. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma It rose to about 32% at score 6, 50% at 7, and over 80% at 8 or above.12PubMed Central. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma People with weaker livers were also less likely to recover from the damage.12PubMed Central. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma Another group saw moderate or worse liver damage in about 18% overall, and liver function score was the main predictor.13PubMed Central. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters

The score combines several measures: blood tests for bilirubin and albumin, clotting time, fluid in the belly, and confusion related to liver disease. A 5 or 6 usually reflects well-preserved function and higher numbers reflect more impairment. Since it rests on blood tests and exam findings, it can change over time, so ask for your most recent result.

The liver can regenerate and has a large reserve, but a liver already damaged by cirrhosis has less spare capacity to absorb radiation injury. Many people treated with liver SBRT have a tumor because of cirrhosis, so the liver around the tumor is often not normal tissue.

Liver damage usually shows up as a worsening liver score on blood tests rather than sudden illness, and blood tests after treatment are how it is caught. Signs can include fluid in the belly, yellowing skin or tiredness.

Before liver SBRT, ask your current Child-Pugh score and how much healthy liver will remain outside the high-dose area. If your score is 7 or higher, ask about alternatives and expected recovery.

Spine Fracture Risk After Spinal SBRT

The main risk is vertebral compression fracture, where a spinal bone collapses, and it is more common after SBRT than after standard radiation, which carries about 5% risk.14PubMed. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases Around 14% of treated bones fractured, with about two thirds of those in the first 4 months.15PubMed Central. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score In another large group, cumulative risk reached 11% at one year and 21% at three years.16PubMed Central. Risk Factors for Vertebral Compression Fracture Following Spine Stereotactic Body Radiation Therapy

Higher doses per session, 24 Gy or more, carried the greatest fracture risk.15PubMed Central. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score An existing fracture, a tumor that eats away bone, and spinal curvature also raised risk.15PubMed Central. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score Women and lower-back tumors had somewhat higher risk.16PubMed Central. Risk Factors for Vertebral Compression Fracture Following Spine Stereotactic Body Radiation Therapy Damage to the spinal cord itself is rare but serious, and doctors plan carefully to avoid it.14PubMed. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases

A spine fracture typically causes back pain at the treated level, often worse with standing or movement and eased by lying down. Because the cancer itself can cause back pain, imaging is how doctors tell a fracture from tumor pain. Report new or worsening back pain after treatment. Numbness, weakness or bladder changes need urgent attention.

Some fractures are painless and found only on a scan, and these may just be watched. Painful ones may be treated with pain medicine and a brace, or with cement injected into the bone to stabilize it. Severe or unstable fractures may need surgery to support the spine, depending on how much the bone has collapsed.

Prostate and Bowel Side Effects

About 9% of men had moderate urinary problems such as painful urination, urgency or weak flow.17PubMed Central. Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study At one center, about 31% had at least moderate urinary symptoms within 2 years, with serious problems rare.18PubMed Central. Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience Moderate bowel effects, mostly rectal bleeding, occurred in about 4%, with no severe bowel cases.17PubMed Central. Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study Several of the men with bowel bleeding were on the blood thinner warfarin.17PubMed Central. Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study The reported urinary rates differ because studies use different doses, techniques, follow-up times and ways of scoring symptoms, so the numbers are not directly comparable.

The prostate wraps around the urethra, so radiation that treats the prostate also irritates the urethra and nearby bladder. Swelling after treatment can narrow the urethra, causing slower flow, urgency or frequent night trips to the bathroom. Men who already had urinary symptoms tend to have more trouble, so describe your baseline. Symptoms may return months later as a temporary flare, and medicines that relax the prostate or calm the bladder usually help. Blood in the urine or being unable to urinate needs prompt contact.

Dose matters a great deal. Moderate late urinary problems were seen in 5% at 35 Gy versus 48% at 40 Gy.19PubMed Central. Prostate SBRT: An Overview of Genitourinary / Rectal Toxicity and Dose Response At the highest trial dose of 50 Gy, 10% had severe rectal injury and most needed a colostomy.19PubMed Central. Prostate SBRT: An Overview of Genitourinary / Rectal Toxicity and Dose Response Ask what total dose you are being offered and why.

Who Faces Serious or Fatal Risks

Interstitial lung disease (ILD), a condition that scars lung tissue, sharply raises danger: severe lung inflammation occurred in 32% versus 2% without it.20PubMed. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease About 21% of people with ILD died of lung inflammation in that group.20PubMed. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease Certain markings on a CT scan and high blood levels of two lung proteins flagged people at high risk.6PubMed Central. Radiation pneumonitis after stereotactic radiation therapy for lung cancer

Radiation can trigger a sudden worsening of the scarring disease, even after a small treated area, which is why your team may ask for breathing tests and a detailed chest scan first. For some people with serious scarring, doctors still consider SBRT because the cancer is dangerous and other options are limited. Ask directly how your lung disease changes your expected risk and what the alternatives are.

For tumors very near the central airways, severe side effects occurred in about 6% and treatment-related deaths in about 4%, most from coughing up blood.21PubMed. Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines Blood thinners, lung scarring disease, tumors inside an airway, and targeted cancer drugs raised fatal risk.21PubMed. Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines Tumors touching the main airway branches carried much higher death risk than nearby tumors.22PubMed Central. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree Ask whether your tumor touches a main airway and whether the dose can be spread over more sessions to lower risk. Coughing up blood after treatment is an emergency.

Immunotherapy given alongside lung SBRT raised severe lung inflammation to about 11% versus none without it.23PubMed Central. Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis Blood-vessel-blocking cancer drugs given within 3 months after SBRT led to bowel injury in an estimated 38% by 6 months.24PubMed. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT) Tell your radiation team about every cancer drug and blood thinner you take or plan to start. Ask your oncologists to coordinate when drugs start relative to SBRT, and do not stop blood thinners on your own; ask how they affect your risk.

Risks From Marker Placement Before Treatment

Some SBRT uses tiny metal markers placed in or near the tumor so the machine can track it. Placing markers in the lung can collapse the lung by letting air into the chest, sometimes requiring a chest tube.25Radiologyinfo.org. Fiducial Marker Placement In a large group, about 13% had minor and 5% had major complications from placement.26PubMed Central. Risks and Benefits of Fiducial Marker Placement in Tumor Lesions for Robotic Radiosurgery: Technical Outcomes of 357 Implantations

The needle passes through the lung’s outer lining, and air can leak into the space around the lung and partly collapse it. A small collapse often causes few symptoms and may heal on its own, while a larger one can cause breathlessness and chest pain. People with emphysema or other lung disease are more likely to have a collapse because their lung tissue is more fragile, and tumors deeper in the lung usually need the needle to travel farther.

Placement is done with a needle under scan guidance, often as an outpatient. You may be watched for some hours with a chest X-ray afterward. Sudden chest pain or breathlessness afterward should be reported at once. Mention any lung disease and any blood thinners beforehand so the team can plan, and ask whether markers are needed or whether your machine can track without them.

Ways to Lower Your Risk

For prostate SBRT, MRI-guided machines that adjust the plan daily cut moderate urinary effects from about 28% to 16% and bowel effects from 9% to 4%.27PubMed. Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: A systematic review and meta-analysis The risk of a new cancer caused by the radiation is low and estimated to be lower than with older radiation methods.28PubMed. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy

Tumors in the lung and liver move as you breathe, so machines use techniques such as breath-holding or tracking to follow them. Better tracking lets the team use a smaller treatment area, so less healthy tissue gets a high dose. It is reasonable to ask which motion-control method your center uses.

Re-treating the chest with SBRT is possible, but severe and fatal effects do occur and are hard to predict.29PubMed. Review of thoracic reirradiation with stereotactic body radiation therapy: A focus on toxicity risks Repeat spinal SBRT with careful limits caused no spinal cord damage in one large group.30PubMed. Oncological outcomes and safety after spinal reirradiation with stereotactic body radiotherapy